ArticleNPJ precision oncology2026

Efficacy and safety of surufatinib and sintilimab with or without chemotherapy for advanced high-grade neuroendocrine neoplasms and pancreatic cancer.

Zhi Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.